- PTCT +1.92%
News Flash: Analysts Just Made A Notable Upgrade To Their PTC Therapeutics, Inc. (NASDAQ:PTCT) Forecasts
Yahoo Finance · 2 weeks ago
Open | 37.51 |
High | 38.71 |
Low | 37.22 |
Mkt Cap | 2.93B |
P/E (TTM) | N/A |
Div & Yield | N/A & N/A |
Prev. Close | 37.43 |
52 Wk. Low | 17.53 |
52 Wk. High | 45.68 |
Related stocks
Pharmaceutical company
PTC Therapeutics is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control mechanisms in orphan diseases. Wikipedia
(USD) | Q1 2024 | Y/Y |
---|---|---|
Revenue | 210.12M | 4.70% ▼ |
Net Income | -91.58M | - |
Diluted EPS | -1.20 | - |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q2 2024 | -$1.07 | - |
Q1 2024 | -$1.24 | -$1.20 |
Q4 2023 | $0.50 | -$2.06 |
S&P 500^GSPC | 5,284.92+1.52 (+0.03%) |
Dow 30^DJI | 38,677.92+106.89 (+0.28%) |
Nasdaq^IXIC | 16,834.34+5.67 (+0.03%) |
MicroAlgo Inc.MLGO | 10.71+586.84% |
Walmart Inc.WMT | 66.36+0.82% |
Bitcoin USDBTC-USD | 70,304.38+1.81% |